Why AI Isn’t Curing Disease, Yet: Crossing Pharma’s Valley of Death with Physical Intelligence
Noam Solomon, PhD, Co-founder and CEO of Immunai
We were told AI would cure disease in years. That’s a fallacy.
Today, over 90% of clinical drug candidates still fail. It costs more than $2 billion and…
Continue Reading
